Cargando…
Risk Factors for Development of Hemolytic Uremic Syndrome in a Cohort of Adult Patients with STEC 0104:H4 Infection
The outbreak of Shiga toxin producing E.coli O104:H4 in northern Germany in 2011 was one of the largest worldwide and involved mainly adults. Post-diarrheal hemolytic uremic syndrome (HUS) occurred in 22% of STEC positive patients. This study’s aim was to assess risk factors for HUS in STEC-infected...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606481/ https://www.ncbi.nlm.nih.gov/pubmed/23533606 http://dx.doi.org/10.1371/journal.pone.0059209 |
_version_ | 1782264022082519040 |
---|---|
author | Zoufaly, Alexander Cramer, Jakob P. Vettorazzi, Eik Sayk, Friedhelm Bremer, Jan P. Koop, Irmtraut de Weerth, Andreas Schmiedel, Stefan Jordan, Sabine Fraedrich, Katharina Asselborn, Niels H. Nitschke, Martin Neumann-Grutzeck, Christine Magnus, Tim Rüther, Christoph Fellermann, Klaus Stahl, Rolf K. Wegscheider, Karl Lohse, Ansgar W. |
author_facet | Zoufaly, Alexander Cramer, Jakob P. Vettorazzi, Eik Sayk, Friedhelm Bremer, Jan P. Koop, Irmtraut de Weerth, Andreas Schmiedel, Stefan Jordan, Sabine Fraedrich, Katharina Asselborn, Niels H. Nitschke, Martin Neumann-Grutzeck, Christine Magnus, Tim Rüther, Christoph Fellermann, Klaus Stahl, Rolf K. Wegscheider, Karl Lohse, Ansgar W. |
author_sort | Zoufaly, Alexander |
collection | PubMed |
description | The outbreak of Shiga toxin producing E.coli O104:H4 in northern Germany in 2011 was one of the largest worldwide and involved mainly adults. Post-diarrheal hemolytic uremic syndrome (HUS) occurred in 22% of STEC positive patients. This study’s aim was to assess risk factors for HUS in STEC-infected patients and to develop a score from routine hospital parameters to estimate patient risks for developing HUS. In a cohort analysis, adult patients with STEC infection were included in five participating hospitals in northern Germany between May and July 2011. Clinical data were obtained from questionnaires and medical records, laboratory data were extracted from hospitals’ electronic data systems. HUS was defined as thrombocytopenia, hemolytic anemia and acute renal dysfunction. Random forests and multivariate logistic regression were used to identify risk factors for HUS and develop a score using the estimated coefficients as weights. Among 259 adults with STEC infection, vomiting (OR 3.48,95%CI 1.88–6.53), visible blood in stools (OR 3.91,95%CI1.20–16.01), age above 75 years (OR 3.27, 95%CI 1.12–9.70) and elevated leukocyte counts (OR 1.20, 95%CI 1.10–1.31, per 1000 cells/mm(3)) were identified as independent risk factors for HUS. A score using these variables has an area under the ROC curve of 0.74 (95%CI 0.68–0.80). Vomiting, visible blood in stools, higher leukocyte counts, and higher age indicate increased risk for developing HUS. A score using these variables might help to identify high risk patients who potentially benefit from aggressive pre-emptive treatment to prevent or mitigate the devastating consequences of HUS. |
format | Online Article Text |
id | pubmed-3606481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-36064812013-03-26 Risk Factors for Development of Hemolytic Uremic Syndrome in a Cohort of Adult Patients with STEC 0104:H4 Infection Zoufaly, Alexander Cramer, Jakob P. Vettorazzi, Eik Sayk, Friedhelm Bremer, Jan P. Koop, Irmtraut de Weerth, Andreas Schmiedel, Stefan Jordan, Sabine Fraedrich, Katharina Asselborn, Niels H. Nitschke, Martin Neumann-Grutzeck, Christine Magnus, Tim Rüther, Christoph Fellermann, Klaus Stahl, Rolf K. Wegscheider, Karl Lohse, Ansgar W. PLoS One Research Article The outbreak of Shiga toxin producing E.coli O104:H4 in northern Germany in 2011 was one of the largest worldwide and involved mainly adults. Post-diarrheal hemolytic uremic syndrome (HUS) occurred in 22% of STEC positive patients. This study’s aim was to assess risk factors for HUS in STEC-infected patients and to develop a score from routine hospital parameters to estimate patient risks for developing HUS. In a cohort analysis, adult patients with STEC infection were included in five participating hospitals in northern Germany between May and July 2011. Clinical data were obtained from questionnaires and medical records, laboratory data were extracted from hospitals’ electronic data systems. HUS was defined as thrombocytopenia, hemolytic anemia and acute renal dysfunction. Random forests and multivariate logistic regression were used to identify risk factors for HUS and develop a score using the estimated coefficients as weights. Among 259 adults with STEC infection, vomiting (OR 3.48,95%CI 1.88–6.53), visible blood in stools (OR 3.91,95%CI1.20–16.01), age above 75 years (OR 3.27, 95%CI 1.12–9.70) and elevated leukocyte counts (OR 1.20, 95%CI 1.10–1.31, per 1000 cells/mm(3)) were identified as independent risk factors for HUS. A score using these variables has an area under the ROC curve of 0.74 (95%CI 0.68–0.80). Vomiting, visible blood in stools, higher leukocyte counts, and higher age indicate increased risk for developing HUS. A score using these variables might help to identify high risk patients who potentially benefit from aggressive pre-emptive treatment to prevent or mitigate the devastating consequences of HUS. Public Library of Science 2013-03-22 /pmc/articles/PMC3606481/ /pubmed/23533606 http://dx.doi.org/10.1371/journal.pone.0059209 Text en © 2013 Zoufaly et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Zoufaly, Alexander Cramer, Jakob P. Vettorazzi, Eik Sayk, Friedhelm Bremer, Jan P. Koop, Irmtraut de Weerth, Andreas Schmiedel, Stefan Jordan, Sabine Fraedrich, Katharina Asselborn, Niels H. Nitschke, Martin Neumann-Grutzeck, Christine Magnus, Tim Rüther, Christoph Fellermann, Klaus Stahl, Rolf K. Wegscheider, Karl Lohse, Ansgar W. Risk Factors for Development of Hemolytic Uremic Syndrome in a Cohort of Adult Patients with STEC 0104:H4 Infection |
title | Risk Factors for Development of Hemolytic Uremic Syndrome in a Cohort of Adult Patients with STEC 0104:H4 Infection |
title_full | Risk Factors for Development of Hemolytic Uremic Syndrome in a Cohort of Adult Patients with STEC 0104:H4 Infection |
title_fullStr | Risk Factors for Development of Hemolytic Uremic Syndrome in a Cohort of Adult Patients with STEC 0104:H4 Infection |
title_full_unstemmed | Risk Factors for Development of Hemolytic Uremic Syndrome in a Cohort of Adult Patients with STEC 0104:H4 Infection |
title_short | Risk Factors for Development of Hemolytic Uremic Syndrome in a Cohort of Adult Patients with STEC 0104:H4 Infection |
title_sort | risk factors for development of hemolytic uremic syndrome in a cohort of adult patients with stec 0104:h4 infection |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606481/ https://www.ncbi.nlm.nih.gov/pubmed/23533606 http://dx.doi.org/10.1371/journal.pone.0059209 |
work_keys_str_mv | AT zoufalyalexander riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection AT cramerjakobp riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection AT vettorazzieik riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection AT saykfriedhelm riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection AT bremerjanp riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection AT koopirmtraut riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection AT deweerthandreas riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection AT schmiedelstefan riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection AT jordansabine riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection AT fraedrichkatharina riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection AT asselbornnielsh riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection AT nitschkemartin riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection AT neumanngrutzeckchristine riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection AT magnustim riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection AT rutherchristoph riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection AT fellermannklaus riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection AT stahlrolfk riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection AT wegscheiderkarl riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection AT lohseansgarw riskfactorsfordevelopmentofhemolyticuremicsyndromeinacohortofadultpatientswithstec0104h4infection |